Astrana Health, Inc.
ASTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $956,048 | $654,808 | $620,390 | $665,209 |
| % Growth | 46% | 5.5% | -6.7% | – |
| Cost of Goods Sold | $874,451 | $576,839 | $549,061 | $602,193 |
| Gross Profit | $81,597 | $77,969 | $71,329 | $63,016 |
| % Margin | 8.5% | 11.9% | 11.5% | 9.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $113,112 | $50,725 | $43,897 | $41,633 |
| SG&A Expenses | $113,112 | $50,725 | $43,897 | $41,633 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$50,725 | $6,904 | $6,849 | $20,663 |
| Operating Expenses | $62,387 | $57,629 | $50,746 | $62,296 |
| Operating Income | $19,210 | $20,340 | $20,583 | $720 |
| % Margin | 2% | 3.1% | 3.3% | 0.1% |
| Other Income/Exp. Net | -$13,539 | -$3,515 | -$10,979 | -$2,615 |
| Pre-Tax Income | $5,671 | $16,825 | $9,604 | -$1,895 |
| Tax Expense | $4,594 | $6,609 | $3,383 | $5,882 |
| Net Income | $373 | $9,423 | $6,692 | -$6,951 |
| % Margin | 0% | 1.4% | 1.1% | -1% |
| EPS | -0.33 | 0.19 | 0.14 | -0.14 |
| % Growth | -273.7% | 35.7% | 200% | – |
| EPS Diluted | -0.33 | 0.19 | 0.14 | -0.14 |
| Weighted Avg Shares Out | 49,188 | 49,188 | 48,471 | 47,930 |
| Weighted Avg Shares Out Dil | 49,471 | 49,471 | 48,851 | 47,930 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,522 | $2,336 | $2,312 | $3,221 |
| Interest Expense | $17,718 | $7,382 | $7,308 | $8,069 |
| Depreciation & Amortization | $15,595 | $6,904 | $6,849 | $8,126 |
| EBITDA | $38,984 | $31,111 | $23,761 | $14,300 |
| % Margin | 4.1% | 4.8% | 3.8% | 2.1% |